Condensed Consolidated Statements of Changes in Stockholders’ Deficit (unaudited) - USD ($)
|
Series A
Convertible Redeemable Preferred Stock
|
Series B
Convertible Redeemable Preferred Stock
|
Special Voting Preferred Stock |
Common Stock |
Additional Paid-In Capital |
Accumulated Other Comprehensive Income |
Accumulated Deficit |
Total |
Balance at beginning at Dec. 31, 2020 |
|
|
$ 20,405,219
|
$ 100
|
$ 94,088,323
|
$ (91,497)
|
$ (57,179,525)
|
$ 57,222,620
|
Balance at beginning (in Shares) at Dec. 31, 2020 |
|
|
2,667,349
|
995,062
|
|
|
|
|
Conversion of exchangeable shares to common stock |
|
|
$ (18,039,181)
|
$ 12
|
18,039,169
|
|
|
|
Conversion of exchangeable shares to common stock (in Shares) |
|
|
(2,358,063)
|
117,903
|
|
|
|
|
Settlement of convertible notes |
|
|
|
$ 15
|
11,610,571
|
|
|
11,610,586
|
Settlement of convertible notes (in Shares) |
|
|
|
154,706
|
|
|
|
|
Shares withheld for withholding taxes |
|
|
|
$ (1)
|
(520,394)
|
|
|
(520,395)
|
Shares withheld for withholding taxes (in Shares) |
|
|
|
(6,089)
|
|
|
|
|
Shares issued in connection with Viridian acquisition |
|
|
|
$ 5
|
6,187,995
|
|
|
6,188,000
|
Shares issued in connection with Viridian acquisition (in Shares) |
|
|
|
51,550
|
|
|
|
|
Shares issued in connection with asset purchase |
|
|
|
|
300,000
|
|
|
300,000
|
Shares issued in connection with asset purchase (in Shares) |
|
|
|
4,167
|
|
|
|
|
Shares issued (returned) in connection with 365 Cannabis acquisition |
|
|
|
$ 18
|
11,996,043
|
|
|
11,996,061
|
Shares issued (returned) in connection with 365 Cannabis acquisition (in Shares) |
|
|
|
178,572
|
|
|
|
|
Stock-based compensation |
|
|
|
|
2,070,358
|
|
|
2,070,358
|
Shares issued in connection with the ATM offering program |
|
|
|
$ 3
|
1,828,116
|
|
|
1,828,119
|
Shares issued in connection with the ATM offering program (in Shares) |
|
|
|
27,819
|
|
|
|
|
Liabilities with shares |
|
|
|
$ 1
|
430,024
|
|
|
430,025
|
Liabilities with shares (in Shares) |
|
|
|
5,085
|
|
|
|
|
Restricted stock vesting |
|
|
|
$ 2
|
(2)
|
|
|
|
Restricted stock vesting (in Shares) |
|
|
|
21,386
|
|
|
|
|
Forfeitures of restricted shares |
|
|
|
|
|
|
|
|
Forfeitures of restricted shares (in Shares) |
|
|
|
(67)
|
|
|
|
|
Foreign currency translation adjustments |
|
|
|
|
|
53,020
|
|
53,020
|
Unrealized gain (loss) on convertible notes |
|
|
|
|
|
100,000
|
|
100,000
|
Net loss |
|
|
|
|
|
|
(31,328,711)
|
(31,328,711)
|
Balance at ending at Dec. 31, 2021 |
|
|
$ 2,366,038
|
$ 155
|
146,030,203
|
61,523
|
(88,508,236)
|
59,949,683
|
Balance at ending (in Shares) at Dec. 31, 2021 |
|
|
309,286
|
1,550,094
|
|
|
|
|
Conversion of exchangeable shares to common stock |
|
|
$ (18,620)
|
|
18,620
|
|
|
|
Conversion of exchangeable shares to common stock (in Shares) |
|
|
(2,434)
|
122
|
|
|
|
|
Settlement of convertible notes |
|
|
|
$ 17
|
3,299,983
|
|
|
3,300,000
|
Settlement of convertible notes (in Shares) |
|
|
|
169,843
|
|
|
|
|
Shares withheld for withholding taxes |
|
|
|
|
(5,615)
|
|
|
(5,615)
|
Shares withheld for withholding taxes (in Shares) |
|
|
|
(222)
|
|
|
|
|
Shares returned in connection with acquisition |
|
|
|
$ (1)
|
(939,999)
|
|
|
(940,000)
|
Shares returned in connection with acquisition (in Shares) |
|
|
|
(13,988)
|
|
|
|
|
Stock-based compensation |
|
|
|
|
316,855
|
|
|
316,855
|
Issuance of common stock upon vesting of restricted stock units |
|
|
|
|
|
|
|
|
Issuance of common stock upon vesting of restricted stock units (in Shares) |
|
|
|
2,174
|
|
|
|
|
Liabilities with shares |
|
|
|
|
45,066
|
|
|
45,066
|
Liabilities with shares (in Shares) |
|
|
|
732
|
|
|
|
|
Foreign currency translation adjustments |
|
|
|
|
|
(33,800)
|
|
(33,800)
|
Unrealized gain (loss) on convertible notes |
|
|
|
|
|
101,000
|
|
101,000
|
Net loss |
|
|
|
|
|
|
(21,952,893)
|
(21,952,893)
|
Balance at ending at Mar. 31, 2022 |
|
|
$ 2,347,418
|
$ 171
|
148,765,113
|
128,723
|
(110,461,129)
|
40,780,296
|
Balance at ending (in Shares) at Mar. 31, 2022 |
|
|
306,852
|
1,708,755
|
|
|
|
|
Balance at beginning at Dec. 31, 2021 |
|
|
$ 2,366,038
|
$ 155
|
146,030,203
|
61,523
|
(88,508,236)
|
59,949,683
|
Balance at beginning (in Shares) at Dec. 31, 2021 |
|
|
309,286
|
1,550,094
|
|
|
|
|
Net loss |
|
|
|
|
|
|
|
(53,822,928)
|
Balance at ending at Sep. 30, 2022 |
|
|
$ 2,227,619
|
$ 402
|
159,841,800
|
356,028
|
(142,331,164)
|
20,094,685
|
Balance at ending (in Shares) at Sep. 30, 2022 |
|
|
291,192
|
4,023,294
|
|
|
|
|
Balance at beginning at Dec. 31, 2021 |
|
|
$ 2,366,038
|
$ 155
|
146,030,203
|
61,523
|
(88,508,236)
|
59,949,683
|
Balance at beginning (in Shares) at Dec. 31, 2021 |
|
|
309,286
|
1,550,094
|
|
|
|
|
Conversion of exchangeable shares to common stock |
|
|
$ (180,647)
|
|
180,647
|
|
|
|
Conversion of exchangeable shares to common stock (in Shares) |
|
|
(23,614)
|
1,180
|
|
|
|
|
Settlement of convertible notes |
|
|
|
$ 21
|
3,925,479
|
|
|
3,925,500
|
Settlement of convertible notes (in Shares) |
|
|
|
207,427
|
|
|
|
|
Shares withheld for withholding taxes |
|
|
|
|
(9,926)
|
|
|
(9,926)
|
Shares withheld for withholding taxes (in Shares) |
|
|
|
(1,662)
|
|
|
|
|
Shares issued (returned) in connection with 365 Cannabis acquisition |
|
|
|
$ (1)
|
(939,999)
|
|
|
(940,000)
|
Shares issued (returned) in connection with 365 Cannabis acquisition (in Shares) |
|
|
|
(13,988)
|
|
|
|
|
Common shares and warrants issued in connection with unit offering |
|
|
|
$ 217
|
9,178,744
|
|
|
9,178,961
|
Common shares and warrants issued in connection with unit offering (in Shares) |
|
|
|
2,173,913
|
|
|
|
|
Stock-based compensation |
|
|
|
|
843,693
|
|
|
843,693
|
Shares issued in connection with the ATM offering program |
|
|
|
$ 64
|
1,854,501
|
|
|
1,854,565
|
Shares issued in connection with the ATM offering program (in Shares) |
|
|
|
642,956
|
|
|
|
|
Issuance of convertible redeemable preferred stock, net of issue costs |
$ 3,435,600
|
$ 858,900
|
|
|
|
|
|
|
Issuance of convertible redeemable preferred stock, net of issue costs (in Shares) |
400,000
|
100,000
|
|
|
|
|
|
|
Deemed dividends related to convertible redeemable preferred stock |
$ 764,400
|
$ 191,100
|
|
|
(955,500)
|
|
|
(955,500)
|
Deemed dividends related to convertible redeemable preferred stock (in Shares) |
|
|
|
|
|
|
|
|
Redemption of convertible redeemable preferred stock |
$ (4,200,000)
|
$ (1,050,000)
|
|
|
|
|
|
|
Redemption of convertible redeemable preferred stock (in Shares) |
(400,000)
|
(100,000)
|
|
|
|
|
|
|
Liabilities with shares |
|
|
|
|
49,529
|
|
|
49,529
|
Liabilities with shares (in Shares) |
|
|
|
2,196
|
|
|
|
|
Restricted stock vesting |
|
|
|
$ 2
|
49,998
|
|
|
50,000
|
Restricted stock vesting (in Shares) |
|
|
|
20,282
|
|
|
|
|
Fractional share adjustment from stock split |
|
|
|
$ 2
|
(2)
|
|
|
|
Fractional share adjustment from stock split (in Shares) |
|
|
|
20,382
|
|
|
|
|
Foreign currency translation adjustments |
|
|
|
|
|
40,577
|
|
40,577
|
Unrealized gain (loss) on convertible notes |
|
|
|
|
|
245,000
|
|
245,000
|
Net loss |
|
|
|
|
|
|
(79,057,610)
|
(79,057,610)
|
Balance at ending at Dec. 31, 2022 |
|
|
$ 2,185,391
|
$ 460
|
160,207,367
|
347,100
|
(167,565,846)
|
(4,825,528)
|
Balance at ending (in Shares) at Dec. 31, 2022 |
|
|
285,672
|
4,602,780
|
|
|
|
|
Balance at beginning at Mar. 31, 2022 |
|
|
$ 2,347,418
|
$ 171
|
148,765,113
|
128,723
|
(110,461,129)
|
40,780,296
|
Balance at beginning (in Shares) at Mar. 31, 2022 |
|
|
306,852
|
1,708,755
|
|
|
|
|
Conversion of exchangeable shares to common stock |
|
|
$ (119,799)
|
|
119,799
|
|
|
|
Conversion of exchangeable shares to common stock (in Shares) |
|
|
(15,660)
|
783
|
|
|
|
|
Settlement of convertible notes |
|
|
|
$ 4
|
625,496
|
|
|
625,500
|
Settlement of convertible notes (in Shares) |
|
|
|
37,584
|
|
|
|
|
Shares withheld for withholding taxes |
|
|
|
|
(7,552)
|
|
|
(7,552)
|
Shares withheld for withholding taxes (in Shares) |
|
|
|
(337)
|
|
|
|
|
Stock-based compensation |
|
|
|
|
148,444
|
|
|
148,444
|
Issuance of common stock upon vesting of restricted stock units |
|
|
|
|
25,000
|
|
|
25,000
|
Issuance of common stock upon vesting of restricted stock units (in Shares) |
|
|
|
3,011
|
|
|
|
|
Shares issued in connection with the ATM offering program |
|
|
|
$ 9
|
761,169
|
|
|
761,178
|
Shares issued in connection with the ATM offering program (in Shares) |
|
|
|
90,809
|
|
|
|
|
Liabilities with shares |
|
|
|
|
4,464
|
|
|
4,464
|
Liabilities with shares (in Shares) |
|
|
|
732
|
|
|
|
|
Foreign currency translation adjustments |
|
|
|
|
|
10,629
|
|
10,629
|
Unrealized gain (loss) on convertible notes |
|
|
|
|
|
163,000
|
|
163,000
|
Net loss |
|
|
|
|
|
|
(29,565,947)
|
(29,565,947)
|
Balance at ending at Jun. 30, 2022 |
|
|
$ 2,227,619
|
$ 184
|
150,441,933
|
302,352
|
(140,027,076)
|
12,945,012
|
Balance at ending (in Shares) at Jun. 30, 2022 |
|
|
291,192
|
1,841,337
|
|
|
|
|
Common shares and warrants issued in connection with unit offering |
|
|
|
$ 217
|
9,178,744
|
|
|
9,178,961
|
Common shares and warrants issued in connection with unit offering (in Shares) |
|
|
|
217,913
|
|
|
|
|
Stock-based compensation |
|
|
|
|
196,124
|
|
|
196,124
|
Issuance of common stock upon vesting of restricted stock units |
|
|
|
$ 1
|
24,999
|
|
|
25,000
|
Issuance of common stock upon vesting of restricted stock units (in Shares) |
|
|
|
8,045
|
|
|
|
|
Foreign currency translation adjustments |
|
|
|
|
|
27,676
|
|
27,676
|
Unrealized gain (loss) on convertible notes |
|
|
|
|
|
26,000
|
|
26,000
|
Net loss |
|
|
|
|
|
|
(2,304,088)
|
(2,304,088)
|
Balance at ending at Sep. 30, 2022 |
|
|
$ 2,227,619
|
$ 402
|
159,841,800
|
356,028
|
(142,331,164)
|
20,094,685
|
Balance at ending (in Shares) at Sep. 30, 2022 |
|
|
291,192
|
4,023,294
|
|
|
|
|
Balance at beginning at Dec. 31, 2022 |
|
|
$ 2,185,391
|
$ 460
|
160,207,367
|
347,100
|
(167,565,846)
|
(4,825,528)
|
Balance at beginning (in Shares) at Dec. 31, 2022 |
|
|
285,672
|
4,602,780
|
|
|
|
|
Conversion of exchangeable shares to common stock |
|
|
$ (4,896)
|
|
4,896
|
|
|
|
Conversion of exchangeable shares to common stock (in Shares) |
|
|
(640)
|
32
|
|
|
|
|
Settlement of convertible notes |
|
|
|
$ 116
|
1,396,985
|
|
|
1,397,101
|
Settlement of convertible notes (in Shares) |
|
|
|
1,164,251
|
|
|
|
|
Stock-based compensation |
|
|
|
|
109,133
|
|
|
109,133
|
Issuance of common stock upon vesting of restricted stock units |
|
|
|
|
|
|
|
|
Issuance of common stock upon vesting of restricted stock units (in Shares) |
|
|
|
587
|
|
|
|
|
Foreign currency translation adjustments |
|
|
|
|
|
20,429
|
|
20,429
|
Unrealized gain (loss) on convertible notes |
|
|
|
|
|
(14,000)
|
|
(14,000)
|
Net loss |
|
|
|
|
|
|
(2,474,628)
|
(2,474,628)
|
Balance at ending at Mar. 31, 2023 |
|
|
$ 2,180,495
|
$ 576
|
161,718,381
|
353,529
|
(170,040,474)
|
(5,787,493)
|
Balance at ending (in Shares) at Mar. 31, 2023 |
|
|
285,032
|
5,767,650
|
|
|
|
|
Balance at beginning at Dec. 31, 2022 |
|
|
$ 2,185,391
|
$ 460
|
160,207,367
|
347,100
|
(167,565,846)
|
(4,825,528)
|
Balance at beginning (in Shares) at Dec. 31, 2022 |
|
|
285,672
|
4,602,780
|
|
|
|
|
Net loss |
|
|
|
|
|
|
|
(8,151,516)
|
Balance at ending at Sep. 30, 2023 |
|
|
$ 1,907,941
|
$ 1,000
|
164,314,084
|
295,274
|
(175,717,363)
|
(9,199,064)
|
Balance at ending (in Shares) at Sep. 30, 2023 |
|
|
249,504
|
10,002,018
|
|
|
|
|
Balance at beginning at Mar. 31, 2023 |
|
|
$ 2,180,495
|
$ 576
|
161,718,381
|
353,529
|
(170,040,474)
|
(5,787,493)
|
Balance at beginning (in Shares) at Mar. 31, 2023 |
|
|
285,032
|
5,767,650
|
|
|
|
|
Conversion of exchangeable shares to common stock |
|
|
$ (250,981)
|
$ 1
|
250,980
|
|
|
|
Conversion of exchangeable shares to common stock (in Shares) |
|
|
(32,808)
|
1,640
|
|
|
|
|
Settlement of convertible notes |
|
|
|
$ 23
|
114,977
|
|
|
115,000
|
Settlement of convertible notes (in Shares) |
|
|
|
230,000
|
|
|
|
|
Stock-based compensation |
|
|
|
|
108,477
|
|
|
108,477
|
Shares issued in a private placement offering |
|
|
|
$ 100
|
499,900
|
|
|
500,000
|
Shares issued in a private placement offering (in Shares) |
|
|
|
1,000,000
|
|
|
|
|
Foreign currency translation adjustments |
|
|
|
|
|
8,574
|
|
8,574
|
Unrealized gain (loss) on convertible notes |
|
|
|
|
|
(25,000)
|
|
(25,000)
|
Net loss |
|
|
|
|
|
|
(3,081,951)
|
(3,081,951)
|
Balance at ending at Jun. 30, 2023 |
|
|
$ 1,929,514
|
$ 700
|
162,692,715
|
337,103
|
(173,122,425)
|
(8,162,393)
|
Balance at ending (in Shares) at Jun. 30, 2023 |
|
|
252,224
|
6,999,290
|
|
|
|
|
Conversion of exchangeable shares to common stock |
|
|
$ (2,157)
|
|
21,573
|
|
|
|
Conversion of exchangeable shares to common stock (in Shares) |
|
|
(2,720)
|
141
|
|
|
|
|
Settlement of convertible notes |
|
|
|
$ 300
|
1,499,700
|
|
|
1,500,000
|
Settlement of convertible notes (in Shares) |
|
|
|
3,000,000
|
|
|
|
|
Stock-based compensation |
|
|
|
|
100,096
|
|
|
100,096
|
Issuance of common stock upon vesting of restricted stock units (in Shares) |
|
|
|
2,587
|
|
|
|
|
Foreign currency translation adjustments |
|
|
|
|
|
(38,829)
|
|
(38,829)
|
Unrealized gain (loss) on convertible notes |
|
|
|
|
|
(3,000)
|
|
(3,000)
|
Net loss |
|
|
|
|
|
|
(2,594,938)
|
(2,594,938)
|
Balance at ending at Sep. 30, 2023 |
|
|
$ 1,907,941
|
$ 1,000
|
$ 164,314,084
|
$ 295,274
|
$ (175,717,363)
|
$ (9,199,064)
|
Balance at ending (in Shares) at Sep. 30, 2023 |
|
|
249,504
|
10,002,018
|
|
|
|
|